RTI Surgical EV/EBIT
Was ist das EV/EBIT von RTI Surgical?
EV/EBIT von RTI Surgical Holdings, Inc. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu RTI Surgical
Was macht RTI Surgical?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
Unternehmen mit ev/ebit ähnlich RTI Surgical
- Avesoro Resources hat EV/EBIT von N/A
- Core Gold hat EV/EBIT von N/A
- PFSWEB Inc hat EV/EBIT von N/A
- Premier Explosives hat EV/EBIT von N/A
- Immuron hat EV/EBIT von N/A
- Kazia Therapeutics hat EV/EBIT von N/A
- RTI Surgical hat EV/EBIT von N/A
- Neueon Towers hat EV/EBIT von N/A
- BK Technologies Corp hat EV/EBIT von N/A
- ServiceSource International Inc hat EV/EBIT von N/A
- Unichem Laboratories hat EV/EBIT von N/A
- Amarillo Biosciences hat EV/EBIT von N/A
- Aurinia Pharmaceuticals Inc hat EV/EBIT von N/A